In response to the article; “Salivary IgA as a Surrogate Biomarker for Microbial Infections in Postoperative Patients Receiving Chemo-Radio-Therapy for Head and Neck Cancer. J Lab Physicians. 2023;15(2):264-268”

CC BY-NC-ND 4.0 · J Lab Physicians
DOI: 10.1055/s-0043-1775763

Letter to the Editor

Authors

Erkan Topkan

¹Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey
Efsun Somay

²Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey
Uğur Selek

³Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey

References
1 Chavan P, Bhat V, Joshi A. et al. Salivary IgA as a surrogate biomarker for microbial infections in postoperative patients receiving chemo-radio-therapy for head and neck cancer. J Lab Physicians 2023; 15 (02) 264-268
2 Li Y, Jin L, Chen T. The effects of secretory IgA in the mucosal immune system. BioMed Res Int 2020; 2020: 2032057
3 Corthésy B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 2013; 4: 185
4 Zhu Y, Liang J, Wang F, Li J, Wang C, Hou J. Bacterial spectrum analysis and antimicrobial susceptibility study of osteoradionecrosis of the jaw in Southern China. Oral Dis 2022; 28 (07) 2015-2025